SCHEMBL6611085

SCHEMBL6611085

COc1ccc(/C(C#N)=C/c2c(Cl)cncc2Cl)nc1OC1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 14/20 0.43
PDE4B Q07343 17/20 0.41
PDE4A P27815 12/20 0.41
PDE4C Q08493 12/20 0.41
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6611092 1.00 PDE4D (0.43) PDE4DPDE4BPDE4APDE4CFFAR4
SCHEMBL6607425 0.91 KDM4E (0.40) PDE4DPDE4BPDE4APDE4C
SCHEMBL6607423 0.91 KDM4E (0.40) PDE4DPDE4BPDE4APDE4C
SCHEMBL6608418 0.89 CHEK1 (0.35) PDE4DPDE4BPDE4APDE4C
SCHEMBL6605174 0.89 CHEK1 (0.35) PDE4DPDE4BPDE4APDE4C
SCHEMBL6609898 0.88 PDE4D (0.44) PDE4DPDE4BPDE4APDE4C
SCHEMBL6609891 0.88 PDE4D (0.44) PDE4DPDE4BPDE4APDE4C
SCHEMBL6606520 0.87 PDE4B (0.42) PDE4DPDE4BPDE4APDE4C
SCHEMBL6606526 0.87 PDE4B (0.42) PDE4DPDE4BPDE4APDE4C
SCHEMBL6606787 0.83 PDE4D (0.42) PDE4DPDE4BPDE4APDE4CFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882714-B1 SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME SS PHARMACEUTICAL CO (JP) 2004-03-03 EP disclosed
US-5935977-A PHOSPHODIESTERASE IV INHIBITORS, TUMOR NECROSIS FACTOR-ALPHA PRODUCTION INHIBITORS; TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES SS PHARMACEUTICAL CO., LTD. (JP) 1999-08-10 US disclosed
EP-0882714-A1 SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME SS Pharmaceutical Co., Ltd. (JP) 1998-12-09 EP disclosed